DK1014986T3 - Kombination af en inhibitor for monoaminoxidase og en antagonist eller delvis agonist for h5-HT 1 beta - Google Patents

Kombination af en inhibitor for monoaminoxidase og en antagonist eller delvis agonist for h5-HT 1 beta

Info

Publication number
DK1014986T3
DK1014986T3 DK98944376T DK98944376T DK1014986T3 DK 1014986 T3 DK1014986 T3 DK 1014986T3 DK 98944376 T DK98944376 T DK 98944376T DK 98944376 T DK98944376 T DK 98944376T DK 1014986 T3 DK1014986 T3 DK 1014986T3
Authority
DK
Denmark
Prior art keywords
antagonist
beta
inhibitor
combination
monoamine oxidase
Prior art date
Application number
DK98944376T
Other languages
Danish (da)
English (en)
Inventor
Stefan Berg
Svante Ross
Seth-Olov Thorberg
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK1014986T3 publication Critical patent/DK1014986T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK98944376T 1997-09-18 1998-09-09 Kombination af en inhibitor for monoaminoxidase og en antagonist eller delvis agonist for h5-HT 1 beta DK1014986T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9703376A SE9703376D0 (sv) 1997-09-18 1997-09-18 A new combination
EP98944376A EP1014986B1 (en) 1997-09-18 1998-09-09 A COMBINATION OF A MONOAMINE OXIDASE INHIBITOR AND A h5-HT 1 BETA ANTAGONIST OR PARTIAL AGONIST
PCT/SE1998/001602 WO1999013878A1 (en) 1997-09-18 1998-09-09 A COMBINATION OF A MONOAMINE OXIDASE INHIBITOR AND A h5-HT1B ANTAGONIST OR PARTIAL AGONIST

Publications (1)

Publication Number Publication Date
DK1014986T3 true DK1014986T3 (da) 2004-10-25

Family

ID=20408296

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98944376T DK1014986T3 (da) 1997-09-18 1998-09-09 Kombination af en inhibitor for monoaminoxidase og en antagonist eller delvis agonist for h5-HT 1 beta

Country Status (27)

Country Link
US (1) US6159970A (cg-RX-API-DMAC10.html)
EP (1) EP1014986B1 (cg-RX-API-DMAC10.html)
JP (1) JP2001516719A (cg-RX-API-DMAC10.html)
KR (2) KR20010024087A (cg-RX-API-DMAC10.html)
CN (1) CN1278727A (cg-RX-API-DMAC10.html)
AR (1) AR013503A1 (cg-RX-API-DMAC10.html)
AT (1) ATE270889T1 (cg-RX-API-DMAC10.html)
AU (1) AU752719B2 (cg-RX-API-DMAC10.html)
BR (1) BR9812236A (cg-RX-API-DMAC10.html)
CA (1) CA2302204A1 (cg-RX-API-DMAC10.html)
DE (1) DE69825062T2 (cg-RX-API-DMAC10.html)
DK (1) DK1014986T3 (cg-RX-API-DMAC10.html)
EE (1) EE200000146A (cg-RX-API-DMAC10.html)
ES (1) ES2222603T3 (cg-RX-API-DMAC10.html)
HU (1) HUP0100621A2 (cg-RX-API-DMAC10.html)
ID (1) ID25789A (cg-RX-API-DMAC10.html)
IL (1) IL134775A0 (cg-RX-API-DMAC10.html)
IS (1) IS5401A (cg-RX-API-DMAC10.html)
MX (1) MXPA00002616A (cg-RX-API-DMAC10.html)
NO (1) NO20001400L (cg-RX-API-DMAC10.html)
PL (1) PL339368A1 (cg-RX-API-DMAC10.html)
PT (1) PT1014986E (cg-RX-API-DMAC10.html)
SE (1) SE9703376D0 (cg-RX-API-DMAC10.html)
SK (1) SK2832000A3 (cg-RX-API-DMAC10.html)
TR (1) TR200000725T2 (cg-RX-API-DMAC10.html)
WO (1) WO1999013878A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA987804B (cg-RX-API-DMAC10.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957948A (en) * 1988-05-05 1990-09-18 Interface, Inc. Biocidal protective coating for heat exchanger coils
SE9601110D0 (sv) * 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives
WO2002066454A1 (fr) * 2001-02-21 2002-08-29 Sankyo Company, Limited Derives de chromene
US7504395B2 (en) * 2001-07-20 2009-03-17 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
CN101448803A (zh) * 2006-03-17 2009-06-03 阿斯利康(瑞典)有限公司 用作5-ht6调节剂的四氢萘
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
ATE554085T1 (de) 2006-11-30 2012-05-15 Probiodrug Ag Neue inhibitoren von glutaminylcyclase
JP5930573B2 (ja) 2007-03-01 2016-06-15 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤の新規使用
WO2008128985A1 (en) 2007-04-18 2008-10-30 Probiodrug Ag Thiourea derivatives as glutaminyl cyclase inhibitors
PL2475428T3 (pl) 2009-09-11 2015-12-31 Probiodrug Ag Pochodne heterocykliczne jako inhibitory cyklazy glutaminowej
ES2586231T3 (es) 2010-03-03 2016-10-13 Probiodrug Ag Inhibidores de glutaminil ciclasa
MX2012010470A (es) 2010-03-10 2012-10-09 Probiodrug Ag Inhibidores heterociclicos d ciclasa de glutaminilo (qc, ec .3 2. 5).
US8541596B2 (en) 2010-04-21 2013-09-24 Probiodrug Ag Inhibitors
EP2686313B1 (en) 2011-03-16 2016-02-03 Probiodrug AG Benzimidazole derivatives as inhibitors of glutaminyl cyclase
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer
CN110179988A (zh) * 2019-07-10 2019-08-30 王大伟 五羟色胺再摄取抑制剂和单胺氧化酶抑制剂联合在制备治疗抑郁症或早泄药物中的应用
IL321485A (en) * 2022-12-14 2025-08-01 Luminous Mind Inc Treatment of psychological symptoms affecting other medical conditions (PFAOMC)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9119932D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
ES2162792T3 (es) * 1991-09-18 2002-01-16 Glaxo Group Ltd Derivados de benzanilida como antagonistas de 5-ht1d.
SE9601110D0 (sv) * 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives

Also Published As

Publication number Publication date
KR20010024087A (ko) 2001-03-26
PL339368A1 (en) 2000-12-18
US6159970A (en) 2000-12-12
CA2302204A1 (en) 1999-03-25
IS5401A (is) 2000-03-14
BR9812236A (pt) 2000-07-18
DE69825062D1 (de) 2004-08-19
PT1014986E (pt) 2004-10-29
CN1278727A (zh) 2001-01-03
ES2222603T3 (es) 2005-02-01
ATE270889T1 (de) 2004-07-15
WO1999013878A1 (en) 1999-03-25
EP1014986B1 (en) 2004-07-14
AU9193198A (en) 1999-04-05
NO20001400L (no) 2000-05-05
SE9703376D0 (sv) 1997-09-18
NO20001400D0 (no) 2000-03-17
AU752719B2 (en) 2002-09-26
JP2001516719A (ja) 2001-10-02
SK2832000A3 (en) 2000-09-12
ZA987804B (en) 1999-03-18
EE200000146A (et) 2001-02-15
ID25789A (id) 2000-11-02
AR013503A1 (es) 2000-12-27
TR200000725T2 (tr) 2000-08-21
KR20010024084A (ko) 2001-03-26
DE69825062T2 (de) 2005-08-25
EP1014986A1 (en) 2000-07-05
MXPA00002616A (es) 2002-04-24
HUP0100621A2 (hu) 2001-08-28
IL134775A0 (en) 2001-04-30

Similar Documents

Publication Publication Date Title
EE200000146A (et) Monoamiini oksüdaasi inhibiitori kombinatsioon h5-HT 1B antagonisti või osalise agonistiga
DK1014985T3 (da) Kombination af en 5-HT-genoptagelsesinhibitor og en h5-HT1B-antagonist eller delvis agonist
EP1109543A4 (en) NITROSO AND NITROSYL COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS, COMPOSITIONS AND USES OF USE
ID25667A (id) Metode dan peralatan untuk jalur lebar (wideband) predistorsi liniersasi
NO973048D0 (no) Elastiske sementsammensetninger og fremgangsmåter
EE9900030A (et) HPPD geen ja inhibiitorid
DK1100459T3 (da) Sammensætning af skummende olie og dens anvendelse
NO961432D0 (no) Benzofiofener og beslektede forbindelser som östrogen-agonister
NO985828L (no) Viskoelastisk overflateaktivt stoff basert pa gelingssammensetning for service-fluider i borehull
DK0976393T3 (da) Sammensætning indeholdende et opacitetsmiddel eller et perlemorsmiddel og mindst en fed alkohol
EE04265B1 (et) Antimükootilist toimeainet ja atsetaatpuhvrit sisaldavad kompositsioonid
EP0941086A4 (en) NITROSIZED AND NITROSYLATED PHOSPHODIESTERASE INHIBITING COMPOUNDS, COMPOSITIONS AND THEIR USE
DK1047450T3 (da) Kombinationer af ACE-inhibitorer og MMP-inhibitorer
HUP9801227A3 (en) Pharmaceutical compositions comprising monoamine oxidase b inhibitors and their use
IS4585A (is) Samsetning 5-HT upptöku-hemils og valkvæðs 5-HT 1A -mótlyfs
NO995545D0 (no) Korrosjonsinhibitor med lav toksisitet
DK0904690T3 (da) Hønsehusudstyr og fremgangsmåde til at holde fjerkræ
NO983481D0 (no) Sementadditiver og sementsammensetninger som omfatter nevnte additiver
DK1293687T3 (da) Dykker med vinklet spids og fremgangsmåde til formning af samme
NO990913L (no) Naftylforbindelser, intermediater, sammensetninger og metoder for anvendelse
IS5408A (is) Samsetning valvísra 5-HT1A mótlyfja og valvíss h5-HT1B mótlyfs eða gerandefnis með hlutaverkun
NO973047D0 (no) Elastiske sementsammensetninger og fremgangsmåter
BR9807696B1 (pt) método para eliminação de ervas daninhas e uso de uma mistura.
DK0920330T3 (da) hCG og derivater som inhibitorer af matrixmetalloproteaser
HK1032738A (en) A combination of a monoamine oxidase inhibitor and a h5-ht 1 beta antagonist or partial agonist